hydroperoxyisophosphamide has been researched along with ifosfamide in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwata, T; Kasai, H; Makino, I; Matsumoto, S; Shiratori, O; Takamizawa, A; Takase, S; Uchida, N; Yamaguchi, K | 1 |
| Fujimoto, S; Horikoshi, N; Hoshino, A; Inagaki, J | 1 |
| Iwata, T; Makino, I; Matsumoto, S; Takamizawa, A | 1 |
| Camerman, A; Camerman, N; Smith, HW | 1 |
| Camerman, A; Camerman, N; Fawcett, JK | 1 |
| Allenbacher, A; Botzler, C; Issels, R; Meier, T; Mueller, E; Multhoff, G; Wiesnet, M | 1 |
| Issels, RD; Meier, TH; Müller, E; Multhoff, G; Wilmanns, W | 1 |
| Apfel, R; Bogdahn, U; Dekant, A; Jäger, AH; Pfeufer, B | 1 |
| Harstrick, A; Klaassen, U; Schleucher, N; Schröder, J; Seeber, S; Vanhoefer, U; Wilke, H | 1 |
| Flentje, M; Latz, D; Manegold, C; Schraube, P; Schulze, T; Weber, KJ | 1 |
| Asakura, S; Kano, Y; Suzuki, K; Takagi, T; Yazawa, Y | 1 |
| Latz, D; Weber, KJ | 1 |
| Beck-Schimmer, B; Biber, J; Hernando, N; Murer, H; Patzer, L; Ziegler, U | 1 |
| Blicharski, K; Fedoročko, P; Mazur, L; Mikeš, J; Niemeyer, U; Opydo-Chanek, M; Śladowska, K | 1 |
14 other study(ies) available for hydroperoxyisophosphamide and ifosfamide
| Article | Year |
|---|---|
Synthesis and antitumor activity of preactivated isophosphamide analogues bearing modified alkylating functionalities.
Topics: Alkylating Agents; Animals; Cell Survival; Cyclophosphamide; Ifosfamide; In Vitro Techniques; Leukemia L1210; Methods; Mice; Mice, Inbred Strains; Stereoisomerism | 1978 |
Combination chemotherapy of 6-thioguanine with various antitumor agents against murine leukemia L-1210.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Resistance; Drug Therapy, Combination; Female; Ifosfamide; Leukemia L1210; Male; Mesylates; Mice; Mitomycins; Nitrosourea Compounds; Thioguanine; Tosyl Compounds | 1977 |
Synthesis, stereochemistry and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and related compounds.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Ifosfamide; Leukemia L1210; Mice; Molecular Conformation | 1977 |
Activated cyclophosphamide anticancer drugs: molecular structures of cis- and trans-4-hydroperoxyisophosphamides.
Topics: Chemical Phenomena; Chemistry; Cyclophosphamide; Ifosfamide; Isomerism; Models, Molecular; X-Ray Diffraction | 1983 |
Structures of two isomeric bicyclic derivatives of 4-hydroperoxyisophosphamide.
Topics: Crystallization; Cyclophosphamide; Ifosfamide; Isomerism; Magnetic Resonance Spectroscopy; Models, Molecular | 1983 |
Ifosfamide induced depletion of glutathione in human peripheral blood lymphocytes and protection by mesna.
Topics: Acetaldehyde; Acrolein; Animals; CHO Cells; Cricetinae; Glutathione; Humans; Ifosfamide; Intracellular Fluid; Lymphocytes; Mesna | 1994 |
Ifosfamide induced stress response in human lymphocytes.
Topics: Blotting, Western; Cells, Cultured; DNA; Glutathione; Heat-Shock Proteins; Humans; Ifosfamide; Interleukin-2; Isoelectric Focusing; Kinetics; Lymphocyte Activation; Lymphocytes; Mesna; Recombinant Proteins; Stress, Physiological; Thymidine | 1993 |
In vitro studies on interaction of 4-hydroperoxyifosfamide and 2-mercaptoethanesulphonate in malignant gliomas.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Interactions; Drug Screening Assays, Antitumor; Glioma; Humans; Ifosfamide; Mesna; Models, Biological; Tumor Cells, Cultured | 1993 |
Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Interactions; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Ifosfamide; Ovarian Neoplasms; Paclitaxel; Tritium; Tumor Cells, Cultured | 1996 |
Combined effects of ionizing radiation and 4-hydroperoxyfosfamide in vitro.
Topics: Animals; Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Colonic Neoplasms; Combined Modality Therapy; Cricetinae; Cricetulus; Female; Humans; Ifosfamide; In Vitro Techniques; Lung; Melanoma; Radiation Dosage; Radiation Tolerance; Radiation, Ionizing; Survival Analysis; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1998 |
Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Ifosfamide; Tumor Cells, Cultured | 1999 |
Transient DNA double-strand breakage in 4-hydroperoxyifosfamide-treated mammalian cells in vitro does not interact with the rejoining of radiation-induced double-strand breaks.
Topics: Animals; Cell Survival; Colonic Neoplasms; Cricetinae; Cricetulus; DNA; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Humans; Ifosfamide; Radiation Dosage; Tumor Cells, Cultured | 2002 |
Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells.
Topics: Acetaldehyde; Animals; Antineoplastic Agents, Alkylating; Biological Transport; Cell Death; Cell Line; Dose-Response Relationship, Drug; Gene Expression Regulation; Ifosfamide; Kidney; Mesna; Opossums; Phosphates; Phosphoramide Mustards; RNA, Messenger; Sodium-Phosphate Cotransporter Proteins, Type IIa | 2006 |
Comparison of
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Membrane; Cell Survival; Cyclophosphamide; Esterases; Gene Expression Regulation, Neoplastic; Humans; Ifosfamide; Leukemia; Membrane Potential, Mitochondrial | 2017 |